Nagaileben Co., Ltd.

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-05-10 EDT 5-day change 1st Jan Change
2,414 JPY +1.22% Intraday chart for Nagaileben Co., Ltd. +2.99% +1.34%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 2024 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and the Fiscal Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd.'s Equity Buyback announced on June 29, 2023, has expired with 454,300 shares, representing 1.41% for ¥999.81 million. CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending Feb. 2024 and the Fiscal Year Ending August 2024 CI
Nagaileben Co., Ltd. Announces Dividend for the Year Ended August 2023; Payable on November 27, 2023; Provides Dividend Guidance for the Year Ending August 2024 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023. CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.55% for ¥1,000 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2023 and Full Year Ending August 2023 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2023 CI
Nagaileben Co., Ltd. Provides consolidated Earnings guidance for the fiscal year Ending August 31, 2022 CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2022 CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022. CI
Nagaileben Co., Ltd.'s Equity Buyback announced on May 16, 2022, has expired with 132,700 shares, representing 0.4% for ¥254.65 million. CI
Nagaileben Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 0.62% for ¥400 million. CI
Nagaileben Co., Ltd. authorizes a Buyback Plan. CI
Nagaileben's Fiscal H1 Profit Tumbles as Sales Fall MT
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on April 4, 2022. CI
Chart Nagaileben Co., Ltd.
More charts
NAGAILEBEN Co., Ltd. is a Japan-based company mainly engaged in the medical wear business. The Company operates medical wear business. The medical wear business purchases and sells medical wear products used by medical professionals and care workers from subsidiaries. In addition, the Company is also engaged in the sale of shoes and other products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
2,414 JPY
Average target price
2,000 JPY
Spread / Average Target
-17.15%
Consensus
  1. Stock Market
  2. Equities
  3. 7447 Stock
  4. News Nagaileben Co., Ltd.
  5. Nagaileben's Fiscal H1 Profit Tumbles as Sales Fall
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW